Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD
Clinical trial NCT05867914 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05867914
- Sponsor
- Third Pole Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-04
- Primary completion
- 2024-02-10
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.